Interaction of non-alcoholic fatty liver disease with other liver diseases

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 767-781

  Clouston, Andrew D ^a   Powell, Elizabeth E ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Alcohol; Co factor; Hepatitis C; Non alcoholic steatohepatitis; Orthotopic liver transplantation; Weight reduction

Indexed keywords

IRON; METHOTREXATE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IRON STORAGE; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER TRANSPLANTATION; OBESITY; REVIEW; WEIGHT REDUCTION; BODY MASS; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; GENETICS; METABOLISM; RISK FACTOR; FATTY ACID OXIDATION; GENOTYPE; GRAFT FAILURE; LIVER CIRRHOSIS; LIVER INJURY; LYMPHOCYTIC INFILTRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREVALENCE; PROTEIN EXPRESSION;

BODY MASS INDEX; DISEASE PROGRESSION; FATTY LIVER; HEPATITIS C, CHRONIC; HEPATITIS, ALCOHOLIC; HUMANS; IRON; LIVER DISEASES; LIVER TRANSPLANTATION; OBESITY; RISK FACTORS;

EID: 0036783296     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0329     Document Type: Article

References (71)

1. Brunt E M Nonalcoholic steatohepatitis: definition and pathology Seminars in Liver Disease 21 2001 3-16
2. Matteoni C A Younossi Z M Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413-1419
3. Ishak K G Chronic hepatitis: morphology and nomenclature Modern Pathology 7 1994 690-713
4. Teli M R James O F Burt A D et al. The natural history of nonalcoholic fatty liver: a follow-up study Hepatology 22 1995 1714-1719
5. Day C P James O FW Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463-1466
6. Ramrakhiani S Cordes B Brunt E M et al. Concurrence of steatohepatitis with chronic hepatitis C and other chronic liver diseases Gastroenterology 120 2001 117 Abstract
7. Hourigan L F Macdonald G A Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215-1219
8. Clouston A D Jonsson J R Purdie D M et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation Journal of Hepatology 34 2001 314-320
9. Scheuer P J Ashrafzadeh P Sherlock S et al. The pathology of hepatitis C Hepatology 1 1992 567-571
10. Bach N Thung S N Schaffner F The histological features of chronic hepatitis C and autoimmune chronic hepatitis C: a comparative analysis Hepatology 15 1992 572-577
11. Lefkowitch J H Schiff E R Davis R L et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B Gastroenterology 104 1993 595-603
12. Adinolfi L E Gambardella M Andreana A et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358-1364
13. Jonsson J R Edwards-Smith C J Purdie D et al. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Reply Hepatology 30 1999 1531-1532
14. Moriya K Yotsuyanagi H Shintani Y et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice Journal of General Virology 78 1997 1527-1531
15. Schwarz K B Larroya S Vogler C et al. Role of influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse model of Reye syndrome Hepatology 13 1991 96-103
16. Fiore G Fera G Napoli N et al. Liver steatosis and chronic hepatitis C: a spurious association? European Journal of Gastroenterology and Hepatology 8 1996 125-129
17. Wong V S Wight D G Palmer C R Alexander G J Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model Journal of Clinical Pathology 49 1996 465-469
18. Czaja A J Carpenter H A Santrach P J Moore S B Host- and disease-specific factors affecting steatosis in chronic hepatitis C Journal of Hepatology 29 1998 198-206
19. Giannini E Ceppa P Botta F et al. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients Liver 19 1999 432-437
20. Rubbia-Brandt L Quadri R Abid K et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 Journal of Hepatology 33 2000 106-115
21. Hwang S J Luo J C Chu C W et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation Journal of Gastroenterology and Hepatology 16 2001 190-195
22. Ong J P Younossi Z M Speer C et al. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease Liver 21 2001 266-271
23. Day C P James O FW Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842-845
24. Chavin K D Yang S Lin H Z et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion Journal of Biological Chemistry 274 1999 5692-5700
25. Arsenijevic D Onuma H Pecqueur C et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production Nature Genetics 26 2000 435-439
26. Hickman I J Clouston A D Macdonald G A et al. The effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C Gut 51 2002 89-94
27. Naveau S Giraud V Borotto E et al. Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108-111
28. Iturriaga H Bunout D Hirsch S Ugarte G Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics American Journal of Clinical Nutrition 47 1988 235-238
29. Reeves H L Burt A D Wood S Day C P Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis Journal of Hepatology 25 1996 677-683
30. de la Maza M P Hirsch S Petermann M et al. Changes in microsomal activity in alcoholism and obesity Alcoholism, Clinical and Experimental Research 24 2000 605-610
31. Mezey E Dietary fat and alcoholic liver disease Hepatology 28 1998 901-905
32. Robertson G Leclercq I Farrell G C Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress American Journal of Physiology. Gastrointestinal and Liver Physiology 281 2001 G1135-G1139
33. Bunout D Munoz C Lopez M et al. Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients American Journal of Clinical Nutrition 63 1996 373-376
34. Casini A Alcohol-induced fatty liver and inflammation: where do Kupffer cells act? Journal of Hepatology 32 2000 1026-1030
35. Diehl A M IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines American Journal of Physiology. Gastrointestinal and Liver Physiology 282 2002 G1-G5
36. George D K Goldwurm S MacDonald G A et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311-318
37. Bonkovsky H L Jawaid Q Tortorelli K et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis Journal of Hepatology 31 1999 421-429
38. Mendler M H Turlin B Moirand R et al. Insulin resistance-associated hepatic iron overload Gastroenterology 117 1999 1155-1163
39. Angulo P Keach J C Batts K P Lindor K D Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356-1362
40. Fargion S Mattioli M Fracanzani A L et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis American Journal of Gastroenterology 96 2001 2448-2455
41. Chitturi S Abeygunasekera S Fung C et al. Haemochromatosis gene mutations, hepatic iron content and nonalcoholic steatohepatitis Hepatology 34 2001 A456
42. Vigano M Vergani A Trombini P et al. Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes Gastroenterology 118 2000 986-987
43. Turlin B Mendler M H Moirand R et al. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients American Journal of Clinical Pathology 116 2001 263-270
44. Tsukamoto H Horne W Kamimura S et al. Experimental liver cirrhosis induced by alcohol and iron Journal of Clinical Investigation 96 1995 620-630
45. Bacon B R Farahvash M J Janney C G Neuschwander-Tetri B A Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103-1109
46. Younossi Z M Gramlich T Bacon B R et al. Hepatic iron and nonalcoholic fatty liver disease Hepatology 30 1999 847-850
47. Nitecki J Jackson F W Allen M L et al. Effect of phlebotomy on non-alcoholic steatohepatitis Gastroenterology 118(4) 2000 A1474
48. Desai T K Phlebotomy reduces transaminase levels in patients with non-alcoholic steatohepatitis Gastroenterology 118 2000 A975
49. Bacon B R Hemochromatosis: diagnosis and management Gastroenterology 120 2001 718-725
50. Contos M J Cales W Sterling R K et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transplantation 7 2001 363-373
51. Bissell D M Roulot D George J Transforming growth factor beta and the liver Hepatology 34 2001 859-867
52. Berenguer M Rayon J M Prieto M et al.Are posttransplantation protocol liver biopsies useful in the long term? Liver Transplantation 7 2001 790-796
53. Prieto M Berenguer M Rayon J M et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes Hepatology 29 1999 250-256
54. Kim W R Poterucha J J Porayko M K et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation Transplantation 62 1996 1802-1805
55. Carson K Washington M K Treem W R et al. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient Liver Transplantation and Surgery 3 1997 174-176
56. Molloy R M Komorowski R Varma R R Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation Liver Transplantation and Surgery 3 1997 177-178
57. Charlton M Kasparova P Weston S et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease Liver Transplantation 7 2001 608-614
58. Chinnakotla S Schafer D Radio S J et al. Is nonalcoholic steatohepatitis a systemic disease? Evidence from liver transplantation Hepatology 34 2001
59. Amaro R Montalbano M Acosta R C et al. Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH) Gastroenterology 120 2001 A118
60. Powell E E Cooksley W G Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74-80
61. Caldwell S H Oelsner D H Iezzoni J C et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664-669
62. Poonawala A Nair S P Thuluvath P J Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689-692
63. Ong J Younossi Z M Reddy V et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease Liver Transplantation 7 2001 797-801
64. Charlton M R Kondo M Roberts S K et al. Liver transplantation for cryptogenic cirrhosis Liver Transplantation and Surgery 3 1997 359-364
65. Strasberg S M Howard T K Molmenti E P Hertl M Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation Hepatology 20 1994 829-838
66. Urena M AG Moreno Gonzales E Romero C J et al. An approach to the rational use of steatotic donor livers in liver transplantation Hepato-gastroenterology 46 1999 1164-1173
67. Fishbein T M Fiel M I Emre S et al. Use of livers with microvesicular fat safely expands the donor pool Transplantation 64 1997 248-251
68. Czaja A J Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis Digestive Diseases and Sciences 43 1998 1725-1731
69. Graziadei I W Joseph J J Wiesner R H et al. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency Hepatology 28 1998 1058-1063
70. Chitturi S Farrell G C Etiopathogenesis of nonalcoholic steatohepatitis Seminars in Liver Disease 21 2001 27-41
71. Langman G Hall P Todd G Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury Journal of Gastroenterology and Hepatology 16 2001 1395-1401